RadNet, Inc. 2009 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: RadNet, Inc.
Reporting Period: Fiscal year ended December 31, 2009
Business Overview: RadNet is the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating 180 centers across seven states (California, Delaware, Maryland, New Jersey, Florida, Kansas, and New York). The company offers multi-modality services including MRI, CT, PET, nuclear medicine, mammography, ultrasound, and X-ray. Revenue is derived from a diverse mix of payors, including commercial insurance (56%), managed care capitated payors (15%), Medicare (20%), and Medicaid (3%).
Key Financial Metrics
| Metric | 2009 | 2008 | 2007 |
|---|---|---|---|
| Net Revenue | $524.4 million | $498.8 million | $423.6 million |
| Operating Income | $38.9 million | $29.3 million | $19.3 million |
| Net Loss (Attributable to Common Stockholders) | $(2.3) million | $(12.8) million | $(18.1) million |
| Operating Margin | 7.4% | 5.9% | 4.5% |
| Cash Provided by Operating Activities | $76.6 million | $45.4 million | $25.3 million |
| Total Debt (Notes Payable & Capital Leases) | $451.3 million | $466.3 million | N/A |
| Working Capital | $9.2 million | $2.7 million | $23.2 million |
| Stockholders' Equity Deficit | $(74.8) million | $(81.0) million | $(69.8) million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 5.1% to $524.4 million, driven by a 1.8% increase in volume at existing centers and $71.0 million in revenue from centers acquired after January 1, 2008.
- Profitability Improvement: Operating income increased 32.7% to $38.9 million. The net loss narrowed significantly from $12.8 million in 2008 to $2.3 million in 2009, primarily due to improved operating margins and a $1.4 million gain on a bargain purchase.
- Expense Management: Operating expenses increased 3.5% to $397.8 million. Salaries and professional reading fees decreased 1.0% at existing centers due to cost-cutting measures implemented in late 2008. Building and equipment rental expenses decreased 6.1% at existing centers due to lease conversions.
- Interest Expense: Interest expense decreased to $49.2 million from $51.8 million, excluding a one-time $6.1 million amortization charge related to interest rate swap modifications.
- Acquisitions: The company acquired several facilities in 2009, including nine centers in New Jersey (resulting in a bargain purchase gain), Ridgewood Diagnostics, and Chesapeake Urology Associates.
Guidance, Outlook, Risks, and Unusual Items
- Refinancing Plans: In March 2010, the company entered into a commitment letter to refinance its existing debt. The plan includes a new $100 million revolving credit facility, a $275 million term loan, and a private placement of $210 million in senior unsecured notes. Closing was expected in April 2010.
- Future Acquisitions: The company announced letters of intent to acquire Truxton Medical Group and a New Jersey subsidiary of Health Diagnostics, with consideration of approximately $24.5 million plus stock.
- Regulatory Risks: Significant risks include potential reductions in Medicare reimbursement rates (projected 21.2% reduction for 2010 unless Congress intervenes), changes in the Deficit Reduction Act (DRA) caps on imaging services, and increased scrutiny under the False Claims Act and Stark Law.
- Economic Risks: The company noted that rising unemployment and the number of under-insured patients in 2009 impacted MRI and PET/CT scan volumes. Continued economic instability poses a risk to liquidity and credit availability.
- Unusual Items: A $1.4 million gain on bargain purchase was recorded in 2009 from the acquisition of New Jersey assets from a seller in liquidation. Additionally, $6.1 million of accumulated other comprehensive loss was reclassified to interest expense due to interest rate swap modifications.
Key Facts for Investor Verification
- Debt Maturity Wall: Verify the successful closing of the $585 million refinancing package (term loan, revolver, and notes) scheduled for April 2010 to avoid default on existing facilities maturing in 2011-2013.
- Medicare Reimbursement: Monitor Congressional action regarding the projected 21.2% Medicare Physician Fee Schedule reduction for 2010 and the implementation of DRA caps on technical components.
- Accumulated Deficit: Note the substantial accumulated deficit of $74.8 million and the company's reliance on operating cash flow and refinancing to service $451 million in debt.
- Related Party Transactions: Review the management agreement with Beverly Radiology Medical Group (BRMG), controlled by CEO Dr. Howard Berger, which provides professional services for 87 California facilities and receives 79% of collections as compensation.
- Goodwill Valuation: Goodwill totaled $106.5 million; verify the company's annual impairment testing given the economic downturn and potential revenue pressures.